Artritis idiopática juvenil en el adulto joven. Metodología, objetivos y datos iniciales del registro JUVENSER

Merino, 2005, Evaluation of revised International League of Associations for Rheumatology classification criteria for juvenile idiopathic arthritis in Spanish children (Edmonton 2001), J Rheumatol., 32, 559 Petty, 2004, International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001, J Rheumatol., 31, 390 Stoll, 2008, Comparison of Vancouver and International League of Associations for rheumatology classification criteria for juvenile psoriatic arthritis, Arthritis Rheum., 59, 51, 10.1002/art.23240 Tong, 2013, Consumer perspectives on pediatric rheumatology care and service delivery: a qualitative study, J Clin Rheumatol, 19, 234, 10.1097/RHU.0b013e31829d4e82 Young adults with arthritis: meeting their transitional needs - PubMed [Internet]. [consultado 14 Ago 2021]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/8624630/ Ardoin, 2018, Transitions in Rheumatic Disease: Pediatric to Adult Care, Pediatr Clin North Am., 65, 867, 10.1016/j.pcl.2018.04.007 Conti, 2018, Patients with juvenile idiopathic arthritis become adults: the role of transitional care, Clin Exp Rheumatol., 36, 1086 Southall, 2000, Pediatrics., 106, 1054, 10.1542/peds.106.5.1054 McErlane, 2013, Biologic treatment response among adults with juvenile idiopathic arthritis: results from the British Society for Rheumatology Biologics Register, Rheumatology (Oxford)., 52, 1905, 10.1093/rheumatology/ket248 Vidqvist, 2013, Disease activity of idiopathic juvenile arthritis continues through adolescence despite the use of biologic therapies, Rheumatology (Oxford)., 52, 1999, 10.1093/rheumatology/ket256 Niewerth, 2014, [Therapy of juvenile idiopathic arthritis in early adulthood with biologics: transition from pediatric to adult care], Z Rheumatol., 73, 532, 10.1007/s00393-014-1378-z Hooper, 2013, Malignancies in children and young adults on etanercept: summary of cases from clinical trials and post marketing reports, Pediatr Rheumatol Online J., 11, 35, 10.1186/1546-0096-11-35 Minden, 2012, Long-term outcome of patients with JIA treated with etanercept, results of the biologic register JuMBO, Rheumatology (Oxford)., 51, 1407, 10.1093/rheumatology/kes019 Ruperto, 2010, Long-term safety and efficacy of abatacept in children with juvenile idiopathic arthritis, Arthritis Rheum., 62, 1792, 10.1002/art.27431 Ammerlaan, 2013, An urge for change: transitional care for young adults with juvenile idiopathic arthritis, Patient Educ Couns., 92, 127, 10.1016/j.pec.2013.02.006 Calvo, 2015, Consensus of the Spanish society of pediatric rheumatology for transition management from pediatric to adult care in rheumatic patients with childhood onset, Rheumatol Int., 35, 1615, 10.1007/s00296-015-3273-6 Malviya, 2012, The relationships between adult juvenile idiopathic arthritis and employment, Arthritis Rheum., 64, 3016, 10.1002/art.34499 Secor-Turner, 2011, Living with juvenile arthritis: adolescents’ challenges and experiences, J Pediatr Health Care, 25, 302, 10.1016/j.pedhc.2010.06.004 Packham, 2004, Overview of the psychosocial concerns of young adults with juvenile arthritis, Musculoskeletal Care., 2, 6, 10.1002/msc.52 Archenholtz, 2001, Lower level of education in young adults with arthritis starting in the early adulthood, Scand J Rheumatol., 30, 353, 10.1080/030097401317148552 Castrejón, 2012, [Transitional care programs for patients with rheumatic diseases: review of the literature], Reumatol Clin., 8, 20, 10.1016/j.reuma.2011.06.008 Luque Ramos, 2017, Transition to adult rheumatology care is necessary to maintain DMARD therapy in young people with juvenile idiopathic arthritis, Semin Arthritis Rheum., 47, 269, 10.1016/j.semarthrit.2017.05.003 Stagi, 2014, Comparison of bone mass and quality determinants in adolescents and young adults with juvenile systemic lupus erythematosus (JSLE) and juvenile idiopathic arthritis (JIA), Lupus., 23, 1392, 10.1177/0961203314543916 Stagi, 2010, Cross-sectional and longitudinal evaluation of bone mass in children and young adults with juvenile idiopathic arthritis: the role of bone mass determinants in a large cohort of patients, J Rheumatol., 37, 1935, 10.3899/jrheum.091241 Hämäläinen, 2010, Bone mineral content in young adults with active or inactive juvenile idiopathic arthritis and in controls, Scand J Rheumatol., 39, 219, 10.3109/03009740903337885 Coulson, 2013, Cardiovascular risk in juvenile idiopathic arthritis, Rheumatology (Oxford)., 52, 1163, 10.1093/rheumatology/ket106 NORMATIVA-PROYECTOS-SER.docx [Internet]. [consultado 14 Ene 2023]. Disponible en: https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.ser.es%2Fwp-content%2Fuploads%2F2018%2F06%2FNORMATIVA-PROYECTOS-SER.docx&wdOrigin=BROWSELINK Tollisen, 2021, Treatment Satisfaction With and Adherence to Disease-Modifying Antirheumatic Drugs in Adult Patients With Juvenile Idiopathic Arthritis, Arthritis Care Res., 73, 221, 10.1002/acr.24113 Glerup, 2020, Long-Term Outcomes in Juvenile Idiopathic Arthritis: Eighteen Years of Follow-Up in the Population-Based Nordic Juvenile Idiopathic Arthritis Cohort, Arthritis Care Res., 72, 507, 10.1002/acr.23853 Selvaag, 2016, Disease progression into adulthood and predictors of long-term active disease in juvenile idiopathic arthritis, Ann Rheum Dis., 75, 190, 10.1136/annrheumdis-2014-206034